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Article abstract—Objective: To investigate the frequency and clinical determinants of dementia after ischemic stroke.
Methods: The authors administered neurologic, neuropsychological, and functional assessments to 453 patients (age
72.0 6 8.3 years) 3 months after ischemic stroke. They diagnosed dementia using modified Diagnostic and Statistical
Manual of Mental Disorders, 3rd ed., revised criteria requiring deficits in memory and two or more additional cognitive
domains as well as functional impairment. Results: The authors diagnosed dementia in 119 of the 453 patients (26.3%).
Regarding dementia subtypes, 68 of the 119 patients (57.1%) were diagnosed with vascular dementia, 46 patients (38.7%)
were diagnosed with AD with concomitant stroke, and 5 patients (4.2%) had dementia for other reasons. Logistic
regression suggested that dementia was associated with a major hemispheral stroke syndrome (OR 3.0), left hemisphere
(OR 2.1) and right hemisphere (OR 1.8) infarct locations versus brainstem/cerebellar locations, infarcts in the pooled
anterior and posterior cerebral artery territories versus infarcts in other vascular territories (OR 1.7), diabetes mellitus
(OR 1.8), prior stroke (OR 1.7), age 80 years or older (OR 12.7) and 70 to 79 years (OR 3.9) versus 60 to 69 years, 8 or fewer
years of education (OR 4.1) and 9 to 12 years of education (OR 3.0) versus 13 or more years of education, black race (OR
2.6) and Hispanic ethnicity (OR 3.1) versus white race, and northern Manhattan residence (OR 1.6). Conclusions:
Dementia is frequent after ischemic stroke, occurring in one-fourth of the elderly patients in the authors’ cohort. The
clinical determinants of dementia include the location and severity of the presenting stroke, vascular risk factors such as
diabetes mellitus and prior stroke, and host characteristics such as older age, fewer years of education, and nonwhite
race/ethnicity. The results also suggest that concomitant AD plays an etiologic role in approximately one-third of cases of
dementia after stroke. Key words: Stroke—Cerebrovascular disease—Dementia—Vascular dementia—AD.
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As a primary risk factor for dementia as well as a
leading cause of disability and mortality in the
United States, stroke can be considered to be a major
public health problem. Our understanding of cere-
brovascular disease as a basis for dementia has
evolved during the last century, with an early focus
on arteriosclerotic disease of the small vessels as a
cause of cerebral atrophy and cognitive decline,1,2
shifting to an emphasis on the cumulative volume of
cerebral infarction,3 and then to the multiplicity of
infarcts and the concept of “multi-infarct dementia.”4
Recent studies suggest that dementia after stroke is
a function of a more complex group of determinants,
including infarct characteristics, vascular risk fac-
tors, and host features.5,6 In addition, parallel re-
search efforts into cerebrovascular disease and AD
as bases for dementia have begun to intersect.
Pathologic studies have found that those diseases
frequently coexist7,8 and that concomitant cerebro-
vascular disease helps to determine the severity of
dementia among patients with AD,9,10 suggesting
that “mixed” dementia may be more common than
previously recognized.
From 1988 to 1990, we recruited and examined a
large cohort of ischemic stroke patients and recog-
nized a high frequency11 and a heterogeneous group
of clinical determinants5 of dementia, as noted ear-
lier. From 1994 to 1997, we recruited a second large
cohort of patients to confirm the earlier findings and
identify additional clinical determinants. Here we
present our findings based on our pooled cohort of
453 patients, the largest that has thus far been re-
ported with comprehensive clinical assessments.
Subjects and methods. Subjects. As part of a prospec-
tive study of stroke and dementia, we recruited 585 sub-
jects among patients consecutively admitted to Columbia–
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Presbyterian Medical Center for ischemic stroke. We
recruited 297 of those patients from 1988 to 1990 and the
remaining 288 patients from 1994 to 1997. Eligibility re-
quirements included an age of 60 years or older and a
diagnosis of ischemic stroke within the previous 30 days
confirmed by brain imaging (relevant infarct or normal).
Patients were permitted to be of either sex and any race or
ethnicity and patients with a history of prior stroke were
eligible for inclusion. Patients were excluded when certain
clinical features precluded a reliable assessment of cogni-
tive function, including a Boston Diagnostic Aphasia Ex-
amination12 severity rating ,3, persistent impairment of
consciousness, or a primary language other than English
or Spanish. Additional exclusion criteria included the pres-
ence of a concomitant neurologic disorder potentially af-
fecting cognitive function (e.g., PD) or a severe comorbid
medical illness (e.g., terminal cancer) that would preclude
follow-up throughout the 5-year duration of this prospec-
tive study. Patients were not excluded if a premorbid his-
tory of functional impairment suggested that they might
have concomitant AD. A more detailed description of our
inclusion criteria and assessment methods is available in
another publication.11
This study was approved by the Institutional Review
Board of Columbia-Presbyterian Medical Center, and all
subjects provided informed consent.
Assessment procedures. We performed our initial as-
sessments, not including dementia diagnosis, 7 to 10 days
after stroke. At that time, patients were administered the
Mini-Mental State Examination (MMSE)13 and the Barthel
Index,14 which taps the physical aspects of activities of
daily living. Knowledgeable informants were administered
the Blessed Functional Activity Scale (BFAS),15 which taps
the cognitive aspects of activities of daily living, with a
focus on patients’ prestroke functional capabilities. Infor-
mation regarding the presence or absence of prestroke
functional impairment derived from that initial adminis-
tration of the BFAS was used in the determination of the
dementia subtype among patients meeting operationalized
criteria for dementia, whereas subsequent administrations
of the BFAS focused solely on patients’ functional capabil-
ities at the time of the examination. Regarding other as-
sessments that were performed 7 to 10 days after stroke,
neurologists specializing in stroke administered a struc-
tured neurologic examination and documented any history
of stroke, TIA, or exposure to risk factors for cerebrovascu-
lar disease based on review of medical records and a struc-
tured interview administered to all patients and
knowledgeable informants. Patients also were rated on the
Stroke Data Bank Stroke Severity Scale,16 and a compre-
hensive medical history was recorded. Based on the review
of clinical features and brain imaging performed immedi-
ately after stroke, patients were classified by infarct loca-
tion and stroke syndrome using a modification of the
methods of the Stroke Data Bank. Classifications of stroke
location and syndrome were made independently of the
neuropsychological test results. Three months after stroke,
patients were administered a comprehensive neuropsycho-
logical evaluation and the Hamilton Depression Rating
Scale (HDRS),17 and the MMSE, the Barthel Index, the
BFAS, the neurologic examination, and the Stroke Sever-
ity Scale were repeated.
Neuropsychological evaluation. Cognitive testing was
performed in either English or Spanish, based on the lan-
guage spoken in the subject’s home. We administered a
battery of neuropsychological tests developed for use in
epidemiologic studies of dementia to all subjects.18 This
battery included measures of verbal and nonverbal mem-
ory (the Selective Reminding Test and a multiple-choice
recognition version of the Benton Visual Retention Test),
orientation (the MMSE orientation subtest), language (a
15-item version of the Boston Naming Test, letter and
category fluency tests, and selected items drawn from the
repetition and complex ideation subtests of the Boston Di-
agnostic Aphasia Examination), visuospatial function (the
Rosen Drawing Test and a multiple-choice matching ver-
sion of the Benton Visual Retention Test), verbal and non-
verbal abstract reasoning skills (the Similarities subtest of
the Wechsler Adult Intelligence Scale–Revised and the
Identities and Oddities subtest of the Mattis Dementia
Rating Scale), and attention (cancellation tasks using
shapes and letters as targets).
Diagnostic paradigm. Dementia was diagnosed based
on criteria modified from the Diagnostic and Statistical
Manual of Mental Disorders, 3rd ed., revised (DSM-III-R)19
and consistent with criteria later proposed by the Interna-
tional Workshop of the National Institute of Neurological
Disorders and Stroke–Association Internationale pour la
Recherche et l’Enseignement en Neurosciences (NINDS-
AIREN).20 We required deficits in memory and two or more
additional cognitive domains as determined in the neuro-
psychological evaluation as well as functional impairment
not solely related to physical disability documented with
the Blessed Functional Activity Scale. When patients were
aphasic, we required that they exhibit evidence of nonver-
bal memory impairment. We defined impairment within
any cognitive domain as any neuropsychological test score
within that domain falling below a predetermined cutoff
that was selected in a pilot study. We consider those cut-
offs to be conservative. A pilot study found that interrater
agreement on the diagnosis of dementia was excellent,
with a kappa of 0.96 based on independent judgments
made in a sample of 63 patients.
Clinical subtypes of dementia were defined based on the
temporal association between the onset of the dementia
syndrome and stroke as well as correlations between clini-
cal and neuropsychological features. Essentially, vascular
dementia was defined as the new onset of dementia after
stroke, whereas AD with stroke was diagnosed when func-
tional impairment preceded the index stroke based on the
best historical information. Other potential explanations
for a diagnosis of dementia included alcohol abuse and
depression. Diagnostic agreement on the dementia subtype
was found to be excellent based on the same sample of 63
patients, with a kappa of 0.79.
Statistical analyses. To determine whether any selec-
tion bias might have resulted from our failure to examine a
subset of patients 3 months after stroke, chi-square analy-
ses were performed to compare the patients who were not
examined with the patients who were examined with re-
gard to the location and severity of the presenting stroke,
vascular risk factors, and demographic variables. We then
performed a logistic regression analysis to determine
whether any of the variables found to be related to the
failure to be examined 3 months after stroke in the univar-
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iate analyses ( p , 0.10) would be independently related to
the failure to be examined.
To investigate the clinical correlates of dementia, we
performed chi-square analyses to compare the pooled
group of patients who met criteria for dementia to those
who did not meet criteria for dementia with regard to the
clinical variables summarized above. We next performed a
logistic regression analysis to determine whether any of
the variables found to be relevant in the univariate analy-
ses would be independently related to dementia status. We
then entered depression, operationally defined as a total
score .11 and the acknowledgment of depressed mood of
any severity on the HDRS administered 3 months after
stroke; aphasia; and a variable representing the recruit-
ment cohort into that final model as covariates to adjust
for any confounding effects. In addition, we explored poten-
tial interactions between each of the relevant clinical vari-
ables and each of the primary demographic variables.
Finally, we performed the same set of analyses based
solely on patients diagnosed with vascular dementia and
nondemented stroke patients, excluding patients with AD
with stroke and dementia resulting from other nonvascu-
lar etiologies, to investigate the clinical determinants of
vascular dementia.
Results. Clinical characteristics of patients lost to follow-
up. Of the 585 patients who were initially enrolled in our
study, 453 patients (77.4%; age 72.0 6 8.3 years) were
examined 3 months after ischemic stroke. Of the 132 pa-
tients who were not examined, 26 patients had died, 23
patients were medically ill or too severely impaired neuro-
logically to be assessed, and 83 patients refused follow-up,
had moved, or had been lost to follow-up. Thus, of the 536
patients who could have been examined, 453 (84.5%) were
examined. Patients who were not examined 3 months after
stroke were significantly more impaired than patients who
were examined on the MMSE (20.5 6 6.1 versus 23.2 6
5.3), the Barthel Index (59.4 6 31.8 versus 69.7 6 28.3),
and the Stroke Severity Scale (7.6 6 3.0 versus 6.6 6 3.1)
administered 7 to 10 days after stroke. Chi-square analy-
ses suggested that the failure to be examined 3 months
after stroke was associated with a major hemispheral
stroke syndrome, the mechanism of the index stroke, a
history of myocardial infarction, congestive heart failure,
atrial fibrillation, age, and education. Logistic regression
suggested that the failure to be examined was indepen-
dently associated with a major hemispheral stroke syn-
drome (OR 2.20; 95% CI 1.38 to 3.53), a history of
myocardial infarction (OR 1.49; CI 0.89 to 2.48), congestive
heart failure (OR 1.99; CI 1.11 to 3.56), age 80 years or
older (OR 1.79; CI 1.03 to 3.11) and 70 to 79 years (OR
1.51; CI 0.94 to 2.42) versus 60 to 69 years, and 8 or fewer
years of education versus 9 or more years of education (OR
1.66; CI 1.09 to 2.51).
Frequency and subtypes of dementia after ischemic
stroke. Of the 453 patients who were examined 3 months
after ischemic stroke, 119 patients met criteria for demen-
tia (26.3%; CI 22.2% to 30.3%). Among the 119 stroke
Table 1 Performance in neuropsychological testing performed 3 months after stroke by dementia status
Domain Measure
Possible
scores
Dementia*
Yes (n 5 119) No (n 5 334)
Memory Selective Reminding Test
Total recall 0–72 19.4 6 6.1 35.7 6 9.9
Long-term recall 0–72 6.5 6 4.9 21.2 6 12.8
Delayed recall 0–12 1.1 6 1.5 4.9 6 2.6
Delayed recognition 0–12 6.9 6 2.9 11.0 6 1.4
Benton Visual Retention Test (recognition) 0–10 4.2 6 1.6 6.6 6 2.0
Orientation MMSE Orientation 0–10 7.2 6 2.4 9.2 6 1.4
Language Boston Naming Test (15-item version) 0–15 10.6 6 3.0 13.0 6 2.2
Controlled Oral Word Association Test 01 4.8 6 2.9 8.4 6 4.0
Category Fluency 01 8.0 6 3.6 13.0 6 4.2
Repetition 0–8 7.1 6 1.5 7.6 6 0.9
Comprehension 0–6 3.7 6 1.7 5.2 6 1.1
Visuospatial function Rosen Figure Drawing Test 0–5 1.5 6 1.1 2.6 6 1.1
Benton Visual Retention Test (matching) 0–10 5.4 6 2.2 7.8 6 2.1
Abstract reasoning WAIS-R Similarities subtest (age-scaled score) 1–19 5.8 6 2.1 8.6 6 2.8
Identities & Oddities 0–16 12.4 6 2.3 14.2 6 1.9
Attention Cancellations
Correct hits per minute 01 6.1 6 2.9 11.8 6 4.8
Errors 0–120 3.5 6 5.6 1.2 6 3.2
* Values are means 6 SD. All between-group differences are significant at p , 0.001 by t-test.
MMSE 5 Mini-Mental State Examination; WAIS-R 5 Wechsler Adult Intelligence Scale-Revised.
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patients who met dementia criteria, 68 of the 119 patients
(57.1%) were diagnosed with vascular dementia, 46 pa-
tients (38.7%) were diagnosed with “mixed” dementia (i.e.,
AD with stroke), and 5 patients (4.2%) had dementia for
other reasons.
Performance in neuropsychological testing performed 3
months after stroke stratified by dementia status is pre-
sented in table 1. Although it is not surprising that stroke
patients with dementia were significantly more impaired
than nondemented patients on all neuropsychological mea-
sures because the diagnosis of dementia was based on per-
formance on those neuropsychological measures as well as
the BFAS, note that stroke patients with dementia also
were significantly more impaired than nondemented pa-
tients on the MMSE (19.0 6 6.1 versus 26.2 6 3.5, with
77.4% versus 20.6% receiving a total score ,24), the Bar-
thel Index (64.1 6 34.0 versus 90.3 6 18.1), and the Stroke
Severity Scale (7.7 6 2.8 versus 4.6 6 3.1). Stroke patients
with dementia also received significantly higher total
scores on the HDRS than nondemented patients (6.8 6 5.7
versus 4.3 6 4.3, with 18.0% versus 6.9% receiving a total
score .11 and acknowledging depressed mood).
Clinical determinants of dementia 3 months after ische-
mic stroke. Demographic characteristics, vascular risk
factors, and features of the presenting stroke stratified by
dementia status are shown in tables 2, 3, and 4, respec-
tively. Chi-square analyses suggested that dementia was
associated with age, education, race/ethnicity, sex, predom-
inant language, occupation, and residence. Handedness
also was related to dementia status, with right-handed
patients at greater risk, but small cell sizes precluded our
ability to enter it into the logistic regression analysis.
Among vascular risk factors, dementia was associated with
only diabetes mellitus and a history of prior stroke. Among
features of the presenting stroke, dementia was associated
with more severe hemispheral stroke syndromes, stroke
location, and vascular territory.
As shown in table 5 (Model A), logistic regression sug-
gested that dementia was associated with a major hemi-
spheral stroke syndrome, reflecting the severity of
neurologic impairment; left hemisphere and right hemi-
sphere infarct locations versus brainstem/cerebellar infarct
locations; infarcts in the pooled anterior and posterior ce-
rebral artery territories versus infarcts in other vascular
territories; diabetes mellitus; a history of prior stroke; age
80 years and older and 70 to 79 years versus 60 to 69
years; 8 or fewer years of education and 9 to 12 years of
education versus 13 or more years of education; black race
and Hispanic ethnicity versus white race; and residence in
northern Manhattan. Depression was associated with de-
mentia when it was entered into the final logistic model as
a covariate (OR 3.58; CI 1.59 to 8.10), but the model was
otherwise essentially unchanged. Aphasia and a variable
representing the recruitment cohort were not significantly
related to dementia status when they were entered into
the final logistic model. No interaction terms were signifi-
cantly related to dementia status.
The final logistic model was essentially unchanged
when the analysis was restricted to patients with vascular
dementia and nondemented patients, although the odds
ratios increased for all vascular variables and decreased
for the older age groups (table 5, model B). Atherothrom-
botic and lacunar stroke mechanisms were related to de-
mentia in this model, however, whereas northern
Manhattan residence was not. Depression was associated
with dementia when it was entered into the final logistic
model as a covariate (OR 3.31; CI 1.26 to 8.73), but the
model was otherwise essentially unchanged. Aphasia and
Table 2 Demographic variables by dementia status
Variable
Dementia*
p Value
Yes
(n 5 119)
No
(n 5 334)
Age
$80 y 41 (34.5) 42 (12.6) ,0.001
70–79 y 48 (40.3) 115 (34.4)
60–69 y 30 (25.2) 177 (53.0)
Education
0–8 y 59 (49.6) 106 (31.7) ,0.001
9–12 y 48 (40.3) 134 (40.1)
$13 y 12 (10.1) 94 (28.1)
Race/ethnicity
Black 46 (39.3) 126 (38.4) 0.003
Hispanic 51 (43.6) 98 (29.9)
White 20 (17.1) 104 (31.7)
Sex (male) 48 (40.3) 167 (50.0) 0.070
Predominant language (English) 63 (53.4) 217 (65.0) 0.026
Occupation (unskilled vs other) 77 (65.8) 170 (50.9) 0.005
Handedness (right) 110 (98.2) 299 (91.2) 0.012
Residence (northern Manhattan) 64 (53.8) 149 (44.6) 0.085
* Values are frequencies (within-group percentages). Significance
levels are based on chi-square analyses. Some within-group
percentages are based on an incomplete sample due to small
amounts of missing data.
Table 3 Vascular risk factors by dementia status
Variable
Dementia*
p
Value
Yes
(n 5 119)
No
(n 5 334)
Hypertension 85 (72.0) 246 (73.7) 0.733
Diabetes mellitus 49 (41.2) 107 (32.0) 0.072
Myocardial infarction 16 (13.8) 57 (17.1) 0.410
Angina 28 (24.3) 70 (21.1) 0.466
Atrial fibrillation 12 (10.1) 46 (13.9) 0.292
Congestive heart failure 14 (11.9) 31 (9.4) 0.438
Hypercholesterolemia 24 (20.9) 80 (24.2) 0.471
Consistent cigarette use 61 (51.7) 201 (60.9) 0.081
Consistent alcohol use 53 (44.9) 169 (51.4) 0.229
Prior stroke 37 (31.6) 72 (21.6) 0.029
Prior transient ischemic attack 16 (13.9) 57 (17.3) 0.402
* Values are frequencies (within-group percentages). Significance
levels are based on chi-square analyses. Some within-group
percentages are based on an incomplete sample due to small
amounts of missing data.
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the cohort variable were not significantly related to de-
mentia status. Among potential interaction terms, only the
interaction of sex and a major hemispheral stroke syn-
drome was related to dementia status (OR 5.44; CI 1.15
to 25.65), with women with a major hemispheral stroke
syndrome at disproportionately increased risk of vascular
dementia.
Discussion. The results of our study suggest that
dementia is frequent after ischemic stroke, occurring
in one-fourth of the members of our elderly cohort.
Given that patients who were recruited but did not
undergo the 3-month poststroke dementia assess-
ment had experienced more severe hemispheral
stroke syndromes, tended to be older and less well
educated, and exhibited significantly greater cogni-
tive and functional impairment 7 to 10 days after
stroke than patients who were examined, however, it
is likely that our study underestimated the true fre-
quency of dementia after stroke, as we suggested in
previous work.21 Among the 119 stroke patients who
met dementia criteria, most were diagnosed with
vascular dementia, whereas approximately one-third
of patients were diagnosed with AD with concomi-
tant stroke.
The clinical determinants of dementia that we
identified fall into three categories: 1) stroke charac-
teristics, including the severity and location of the
presenting stroke, with more severe left hemisphere
infarcts in the anterior and posterior cerebral artery
territories of greatest importance; 2) vascular risk
factors, including diabetes mellitus and prior stroke;
and 3) host characteristics, including older age,
fewer years of education, and nonwhite race/ethnic-
ity. Patients who were recruited but did not undergo
the 3-month poststroke dementia assessment more
frequently had a history of myocardial infarction and
congestive heart failure than patients who were ex-
amined, however, suggesting that our study may
have failed to recognize an association between those
disorders and dementia because they were under-
represented in our sample.
Numerous studies have investigated vascular de-
mentia in community-based samples, dementia clin-
ics, and autopsy series,22 but different methods of
recruitment, assessment, and dementia diagnosis
can result in wide variability in both the prevalence
estimates and the clinical determinants that are
reported.23-25 Thus, the few prior epidemiologic stud-
ies of the frequency and determinants of dementia
after stroke that have used methods similar to our
own provide information that is most relevant to the
current study. Pohjasvaara et al.25 recruited a cohort
of patients between the ages of 55 and 85 years with
acute ischemic stroke and assessed 451 of them for
the presence of dementia 3 months after stroke. Con-
sistent with our findings, they reported that 20.0% of
those patients met DSM-III-R criteria for dementia,
with 64.4% of those demented patients diagnosed
with a stroke-related dementia. They later investi-
gated the clinical determinants of dementia among
the 337 members of their cohort who also underwent
MRI of the brain.6 Logistic regression suggested that
dementia was associated with a major dominant
hemispheral syndrome (OR 5.0), a history of prior
cerebrovascular disease (e.g., ischemic stroke, intra-
cerebral hemorrhage, subarachnoid hemorrhage; OR
2.0), aphasia (OR 5.6), and 6 or fewer years of educa-
tion (OR 1.1). That logistic model was essentially
unchanged when patients with “mixed” dementia
were excluded. Although we also found that more
severe left hemisphere stroke syndromes were asso-
ciated with dementia status in our cohort, aphasia
was not related. This discrepancy with regard to the
importance of aphasia may have resulted from differ-
ences between the studies in the methods that were
used for the assessment and diagnosis of dementia.
Pohjasvaara et al. did not require evidence of non-
verbal memory impairment for the diagnosis of de-
mentia in aphasic patients, for example, which may
have contributed to the increased frequency of de-
Table 4 Stroke characteristics by dementia status
Variable
Dementia*
p
Value
Yes
(n 5 119)
No
(n 5 334)
Stroke syndrome
Major dominant hemispheral 14 (11.8) 20 (6.0) 0.003
Major nondominant
hemispheral
19 (16.0) 23 (6.9)
Minor dominant hemispheral 11 (9.2) 48 (14.4)
Minor nondominant
hemispheral
16 (13.4) 49 (14.7)
Lacunar/deep hemispheral 44 (37.0) 120 (35.9)
Brainstem/cerebellar 15 (12.6) 74 (22.2)
Stroke location
Left hemisphere 48 (40.3) 102 (30.6) 0.009
Right hemisphere 49 (41.2) 121 (36.3)
Brainstem/cerebellum 22 (18.5) 110 (33.0)
Vascular territory
Internal carotid artery 6 (5.0) 13 (3.9) 0.015
Anterior cerebral artery 8 (6.7) 8 (2.4)
Middle cerebral artery 63 (52.9) 160 (47.9)
Posterior cerebral artery 20 (16.8) 44 (13.2)
Vertebrobasilar 22 (18.5) 109 (32.6)
Stroke mechanism
Large artery atherosclerosis 28 (23.5) 60 (18.0) 0.443
Cardiac embolism 18 (15.1) 68 (20.4)
Lacunar 44 (37.0) 126 (37.7)
Unknown/other cause 29 (24.4) 80 (24.0)
* Values are frequencies (within-group percentages). Significance
levels are based on chi-square analyses. Some within-group
percentages are based on an incomplete sample due to small
amounts of missing data.
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mentia that they found among those patients in their
study.
Censori et al.26 performed a similar study on a
more highly selected sample of ischemic stroke pa-
tients. Among other criteria, they required that pa-
tients be between the ages of 40 and 79 and have no
history of prior stroke or pre-existing dementia. Pa-
tients underwent dementia assessments 3 months
after stroke, with the diagnosis based on NINDS-
AIREN criteria.20 Censori et al. found that 15 of 110
patients (13.6%) met dementia criteria. They could
not perform a formal multivariate analysis because
of a lack of statistical power, but univariate analyses
suggested that dementia was associated with clinical
features including left hemisphere infarction, total
anterior circulation infarcts, stroke severity, apha-
sia, diabetes mellitus, and atrial fibrillation. Al-
though the frequency of dementia that Censori et al.
reported was notably lower than that recognized in
our study, most likely resulting from their recruit-
ment of a younger sample that was free from prior
stroke and pre-existing dementia, their univariate
findings are compatible with our own.
Regarding stroke as a pathophysiologic basis for
dementia, we found that more severe hemispheral
syndromes as well as infarcts in the left hemisphere
and regions supplied by the anterior and posterior
cerebral arteries, such as the medial frontal and me-
dial temporal lobes, were relevant. Although it is not
surprising that more severe strokes would be associ-
ated with dementia, the role of infarct location is
worthy of comment. It has been suggested that the
left hemisphere is dominant for not only language
but generalized cognitive function, and the results of
our study and others6,26-28 support that hypothesis.
Studies focusing specifically on the consequences of
left hemisphere infarction suggest that even mild
aphasia is associated with deficits in verbal memo-
ry29 and intelligence.30 The involvement of limbic
structures among stroke patients with dementia is
consistent with the hypothesis that the medial fron-
tal and medial temporal lobes are critical compo-
nents of a network subserving memory.31 We also
found that lacunar and atherothrombotic stroke sub-
types were most frequent among patients with vas-
cular dementia. Small, strategically located lesions
typically result from a lacunar stroke mechanism
and tend to produce effects remote from and dispro-
portionate to their size,32 particularly with regard to
the metabolic functioning of limbic structures.33
Regarding vascular risk factors, we found that di-
abetes mellitus was associated with dementia, con-
sistent with the findings of Censori et al.26 Diabetes
mellitus may affect cognitive function through its
Table 5 Logistic models of the clinical determinants of dementia based on all patients (Model A) and patients with vascular dementia
and nondemented patients (Model B)
Variable Model A, OR (95% CI) Model B, OR (95% CI)
Age
$80 vs 60–69 y 12.73 (6.12–26.47) 7.83 (3.17–19.31)
70–79 vs 60–69 y 3.86 (2.12–7.04) 3.07 (1.47–6.38)
Education
#8 vs $13 y 4.07 (1.70–9.76) 3.62 (1.21–10.85)
9–12 vs $13 y 2.96 (1.27–6.90) 2.82 (0.97–8.26)
Race
Black vs white 2.65 (1.28–5.51) 1.69 (0.69–4.13)
Hispanic vs white 3.09 (1.42–6.71) 2.53 (0.99–6.46)
Sex (male vs female) 0.74 (0.43–1.26) 0.84 (0.43–1.65)
Residence (northern Manhattan) 1.57 (0.93–2.62)
Diabetes mellitus 1.80 (1.06–3.04) 2.16 (1.13–4.12)
Prior stroke 1.73 (1.00–3.00) 1.87 (0.96–3.64)
Major hemispheral syndrome 3.05 (1.62–5.77) 3.44 (1.55–7.62)
Stroke location
Left hemisphere vs brainstem/cerebellum 2.12 (1.04–4.28) 3.60 (1.40–9.25)
Right hemisphere vs brainstem/cerebellum 1.80 (0.90–3.62) 2.67 (1.02–7.01)
Vascular territory (ACA and PCA vs other) 1.71 (0.89–3.28) 1.75 (0.78–3.89)
Stroke mechanism
Large artery atherosclerosis vs unknown/other 3.27 (1.27–8.37)
Cardiac embolism vs unknown/other 1.29 (0.46–3.62)
Lacunar vs unknown/other 2.43 (0.97–6.06)
ACA 5 anterior cerebral artery; OR 5 odds ratio; PCA 5 posterior cerebral artery.
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effects on cerebral blood flow,34 particularly with re-
gard to reactivity35 and autoregulation,36 or by serv-
ing as a risk factor for clinically “silent” brain
infarction.37,38 Consistent with the concept of “multi-
infarct dementia,”4 we also noted that prior stroke
was related to dementia, suggesting that the cumu-
lative burden of cerebrovascular lesions is of impor-
tance. That cumulative burden could result from the
number of such lesions, with multiple strategically
located infarcts causing cognitive impairment and
cognitive decline, the total volume of such lesions, or
both characteristics.
Finally, certain host characteristics were relevant
to dementia in our study, specifically older age,
fewer years of education, and nonwhite race/ethnic-
ity. Older age is likely to have served as a surrogate
for concomitant AD in our primary logistic regres-
sion analysis, as suggested by a comparison of the
models presented in table 5, which shows that the
odds ratios for the older age groups were reduced
when patients with clinically diagnosed AD were ex-
cluded from the analysis. In a relevant study, He´non
et al.39 investigated the frequency of preexisting de-
mentia in 202 stroke patients using an informant-
based questionnaire and found that 16.3% of those
patients were demented before stroke onset, suggest-
ing that pre-existing AD may be an important con-
tributor to poststroke dementia. Although the
association between fewer years of education and de-
mentia in our study could be an artifact of inherently
poor test performance among patients who were sim-
ply less well educated, it also could reflect a greater
cognitive reserve,40 and, thus, a greater ability to
remain functionally competent despite an increasing
burden of cerebrovascular disease among patients
with more education. The association between non-
white race/ethnicity and dementia is intriguing, and
our study is unique in its ability to recognize that
association because of the composition of the commu-
nity in which Columbia–Presbyterian Medical Cen-
ter is based. Race/ethnicity could be serving as a
surrogate for variables that were unavailable for our
analyses, including quality and not simply quantity
of education and access to and quality of health care.
Our study has certain limitations. First, we did
not have pathologic confirmation of the dementia
subtype in our patients. Thus, it is possible that we
underenumerated the frequency of concomitant AD
among patients whom we diagnosed with probable
vascular dementia. Our final logistic model was mod-
ified in two important ways when we excluded pa-
tients with clinically diagnosed AD from the
analysis, however, with the odds ratios for all vascu-
lar variables increasing and the odds ratios for the
older age groups decreasing, providing indirect sup-
port for the validity of our method of determining the
dementia subtype. Second, although it was our in-
tention to focus on the clinical determinants of de-
mentia after stroke, we recognize that certain
quantitative brain imaging measures would be likely
to be relevant to dementia status in a multivariate
model.27,28 It is possible that clinical variables such
as a major hemispheral stroke syndrome and age
served as surrogates for brain imaging variables
such as the total volume of infarction and cerebral
atrophy in our analyses, however, suggesting that
the importance of the former variables may have
been overestimated while we may have accounted at
least in part for the effects of the latter variables.
Third, although we recognized that certain host
characteristics were associated with dementia sta-
tus, we did not examine the contribution of genetic
factors. Genetic factors are becoming important in
vascular dementia research, whether as risk mark-
ers, such as the APOE-e4 allele,41 or primary inde-
pendent risk factors, such as Notch3 mutations in
cerebral autosomal dominant arteriopathy with sub-
cortical infarcts and leukoencephalopathy.42,43
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